SCHEMBL14111453

SCHEMBL14111453

C=Cc1cn([C@@H]2OC(CO)C(O)[C@@]2(C)F)c2ncnc(NO)c12

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HIF1A Q16665 2/20 0.42
▸ TP53 P04637 2/20 0.42
▸ STAT6 P42226 1/20 0.42
▸ ADORA3 P0DMS8 6/20 0.39
▸ ADORA2A P29274 5/20 0.39
▸ ADORA1 P30542 3/20 0.39
▸ ADORA2B P29275 2/20 0.39
▸ ADK P55263 4/20 0.39
▸ PAX8 Q06710 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ ALOX15 P16050 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ PRMT5 O14744 2/20 0.35
▸ WDR77 Q9BQA1 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14111447 0.90 HIF1A (0.42) HIF1ATP53STAT6ADORA3ADORA2A
SCHEMBL13598738 0.89 ADORA3 (0.50) HIF1ATP53STAT6ADORA3ADORA2A
SCHEMBL4423773 0.89 ADORA3 (0.50) HIF1ATP53STAT6ADORA3ADORA2A
SCHEMBL13598692 0.89 ADORA3 (0.50) HIF1ATP53STAT6ADORA3ADORA2A
SCHEMBL4424317 0.89 ADORA3 (0.50) HIF1ATP53STAT6ADORA3ADORA2A
SCHEMBL14111464 0.89 ADORA3 (0.37) HIF1ATP53ADORA3ADORA2AADORA1
SCHEMBL14111458 0.89 HIF1A (0.44) HIF1ATP53STAT6ADORA3ADORA2A
SCHEMBL14111503 0.89 HIF1A (0.42) HIF1ATP53STAT6ADORA3ADORA2A
SCHEMBL14111476 0.88 ADORA3 (0.39) HIF1ATP53ADORA3ADORA2AADORA1
SCHEMBL14111456 0.88 HIF1A (0.44) HIF1ATP53STAT6ADORA3ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7405204-B2 Nucleoside compounds for treating viral infections GENELABS TECHNOLOGIES, INC. (US) 2008-07-29 — — US disclosed
US-7405204-B2 Nucleoside compounds for treating viral infections GENELABS TECHNOLOGIES, INC. (US) 2008-07-29 — — US disclosed
Send feedback